Axon Enterprise, Inc. (AXON) Down 16.3% — Time to Trim the Holdings?

  • AXON fell 16.26% to $320.35 from $382.56 the previous trading day
  • Weiss Ratings assigns C- (Hold)
  • Market cap is $34.46B

Axon Enterprise, Inc. (AXON) is under heavy pressure this Friday. The stock was last trading at $320.35 on the NASDAQ, down $62.21 from the prior close of $382.56. The decline extends a punishing stretch for the name. AXON now trades roughly 55.5% below its 52-week high of $719.92, a level reached on November 4, 2025. That means the stock has lost more than half its value in almost exactly a year, and today's drop adds a fresh leg to that slide.

Turnover is running far above normal, with approximately 3.62 million shares traded so far against a 90-day average of roughly 965,625. That is about 3.75 times typical volume, and the session is not yet complete.


Why Axon Enterprise, Inc. Price is Moving Lower

The selloff traces directly to Axon's Q3 results and reduced outlook, released on November 5. Adjusted EPS came in at $1.72 against the $1.90 consensus, an $0.18 miss, even though that figure was up 38.7% from $1.24 a year earlier. Revenue reached $908.55 million versus the $931.13 million expected, a $22.58 million shortfall despite 27.9% year-over-year growth. For a stock priced at a forward P/E of 175.82, a miss on both lines leaves little room for forgiveness.

The guidance cut did more damage than the quarter itself. Management lowered 2026 revenue guidance to $3.61 billion to $3.63 billion, implying about 30% growth, down from a prior range of $3.67 billion to $3.725 billion and growth guidance of 32% to 34%. The Q4 forecast of $990 million to $1.01 billion also fell short of the roughly $1.06 billion the Street expected. The main culprit was three delayed federal Dedrone counter-drone deployments worth about $130 million. Management attributed the delays to slower federal procurement, funding and election-cycle timing, and approval and deployment steps rather than lost demand. That framing may prove accurate, but it still pushes revenue out of the current year.

Profitability added to the concern. Adjusted gross margin fell to 59.2% from 62.7% a year earlier. Full-year free-cash-flow guidance dropped to $350 million to $400 million from $450 million, partly because of inventory investment. Axon also announced a $1.2 billion investment in Skydio, which adds a significant capital commitment at the same moment cash generation guidance is moving lower.

The damage looks company-specific. Rival Motorola Solutions (MSI) was down only 0.95% in a contemporaneous market report, while Industrials peers Northrop Grumman Corporation (NOC) and Vertiv Holdings Co (VRT) were up 1.01% and 3.67%, respectively.


What is the Axon Enterprise, Inc. Rating - Should I Sell?

Weiss Ratings assigns AXON a C- rating. Current recommendation is Hold. A C- sits at the lower edge of Hold territory. It signals a company with real strengths whose risk profile has become difficult to justify at the current valuation, and today's guidance cut does little to change that view.

The firmest support comes from the balance sheet and the operating model. Axon is rated Excellent on the Solvency Index, which matters this week. A company that can commit $1.2 billion to Skydio while absorbing delayed federal revenue needs a financial position strong enough to carry both without strain. The Good rating on the Efficiency Index points to a business that converts its installed base of devices into recurring software and cloud revenue. Even after this quarter's compression, the 59.2% adjusted gross margin is high for a company that also manufactures hardware. That rating stops short of Excellent because the bottom line remains thin. A 6.19% profit margin and a 6.22% ROE show how much of that gross profit is still consumed by heavy spending on research, sales and acquisitions.

The weaker ratings tell a different story. Axon is rated Fair on the Growth Index, which may seem surprising given trailing revenue growth of 35.28%. The rating reflects how little of that top-line expansion has reached earnings: trailing EPS stands at just $2.41. Revenue growth guidance has also now been trimmed to about 30%, so the trajectory is bending in the wrong direction. The Fair Total Return Index reflects a stock that has given back more than half its value from the $719.92 peak. The Weak rating on the Volatility Index is the clearest warning. A 16.26% single-session drop on an earnings miss and guidance cut shows how violently a premium-valued stock can reprice when expectations slip, and it is the main reason the overall rating sits at C- rather than higher.

Within the Industrials sector, AXON trails several peers. Deere & Company (DE, C+), Northrop Grumman Corporation (NOC, C+) and Vertiv Holdings Co (VRT, C+) all carry stronger ratings. TransDigm Group Incorporated (TDG, C) and AB Volvo (publ) (VOLVF, C) also rank ahead, which leaves Axon at the bottom of this peer group on risk-adjusted terms.


About Axon Enterprise, Inc.

Axon Enterprise, Inc. (AXON) is an Industrials company that builds technology for law enforcement, federal agencies, corrections, and increasingly enterprise and military customers. The company was founded as TASER International and is headquartered in Scottsdale, Arizona. Its name remains closely tied to the TASER energy weapon line, which includes the TASER 10 and TASER 7 conducted energy devices. Over the past decade, Axon has expanded well beyond weapons into a connected ecosystem of hardware and software. Its Axon Body cameras and Axon Fleet in-car video systems feed footage into Axon Evidence, the cloud-based digital evidence management platform that sits at the center of the business.

The company's strategy rests on bundling devices with multi-year software subscriptions. That approach creates recurring revenue and deep integration into agency workflows. The software suite includes Axon Records for report management and AI tools such as Draft One, which generates draft police reports from body-camera audio. Through acquisitions including Dedrone and Fusus, Axon has pushed into counter-drone detection and real-time crime center software. Those additions widen its addressable market into federal, critical infrastructure and airspace security customers.

Axon's competitive advantage comes from that integrated platform. Once an agency standardizes on Axon cameras, TASER devices and Evidence storage, switching costs become substantial, and the company can layer on additional modules over time. That position is strong, but it ties a growing share of revenue to government procurement cycles. Those cycles can shift with budgets, funding approvals and election timing.


Investor Outlook

Axon Enterprise, Inc. (AXON) carries a Weiss Rating of C- (Hold). A guidance cut, falling gross margin and reduced free-cash-flow outlook make caution the appropriate stance despite the company's strong balance sheet. Investors should watch whether the roughly $130 million in delayed Dedrone deployments convert into revenue as management expects, whether gross margin recovers toward prior-year levels, and how the $1.2 billion Skydio commitment affects cash generation in 2027. See full rankings of all C- rated Industrials stocks inside the Weiss Stock Screener.

--

This Weiss Instant News Alert was compiled by narrative data technology, our proprietary ratings models and analysis by Weiss Ratings with the intent of providing our readers with the fastest research and independent coverage. Weiss Instant News Alerts have been reviewed by a member of our editorial staff before publication. Please send any questions or comments about this story to [email protected]
Top Tech Stocks
See All »
B
AAPL NASDAQ $356.89
B
NVDA NASDAQ $162.94
B
MSFT NASDAQ $524.64
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $127.42
B
Top Financial Stocks
See All »
A
A
JPM NYSE $345.01
B
V NYSE $425.83
Top Energy Stocks
See All »
B
CVX NYSE $218.69
B
COP NYSE $142.20
Top Health Care Stocks
See All »
B
LLY NYSE $1,447.16
B
JNJ NYSE $286.81
B
ABBV NYSE $295.65
Top Real Estate Stocks
See All »
B
PLD NYSE $128.60
B
EQIX NASDAQ $1,055.87